Skip to content
Screener

Oscar Health OSCR Cash & Equivalents

Cash & Equivalents at other companies

CVS Health logo
CVS HealthCVS
$11.54B-4.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
$28B-8.8%
Centene logo
CenteneCNC
$24.15B+66.4%
Elevance Health logo
Elevance HealthELV
$10.23B+19.5%
Molina Healthcare logo
Molina HealthcareMOH
$4.99B+10.8%
EverQuote logo
EverQuoteEVER
$178.49M+42.8%

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$9.08B+149%
Enterprise value$4.68B+252%
P/S0.7×+0.3×

Profitability

See full
Operating margin0.1%
Net margin-0.3%
FCF margin-8.2%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Oscar Health’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001568651-26-000040
(in thousands)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Net cash (used in) provided by financing activities(3,600)4,873
Increase in cash, cash equivalents and restricted cash equivalents2,025,127709,187
Cash, cash equivalents, restricted cash and cash equivalents—beginning of period2,804,1231,551,118
Cash, cash equivalents, restricted cash and cash equivalents—end of period4,829,2502,260,305
Cash and cash equivalents4,805,1392,236,555
Restricted cash and cash equivalents included in restricted deposits24,11123,750
Total cash, cash equivalents and restricted cash and cash equivalents$4,829,250$2,260,305
Supplemental Disclosures:

Item 1. Financial Statements

FAQ

What is Oscar Health's cash & equivalents?
Oscar Health (OSCR) reported cash & equivalents of $4.83B in Q1 2026.
How has Oscar Health's cash & equivalents changed year-over-year?
Oscar Health's cash & equivalents increased by 113.7% year-over-year, from $2.26B to $4.83B.
What is the long-term trend for Oscar Health's cash & equivalents?
Over 5 years (2020 to 2025), Oscar Health's cash & equivalents has grown at a 27.7% compound annual growth rate (CAGR), from $826.33M to $2.8B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Oscar Health's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude